Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
(NASDAQ: IMDX) Delayed: 4.08 +0.07 (1.75%)
Previous Close $4.01    52 Week High $ 
Open $3.98    52 Week Low $ 
Day High $4.16    P/E N/A 
Day Low $3.85    EPS $ 
Volume 166,012